Previous close | 472.30 |
Open | 476.70 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 475.30 - 483.05 |
52-week range | 352.00 - 545.90 |
Volume | |
Avg. volume | 8,727,654 |
Market cap | 2.506T |
Beta (5Y monthly) | 0.72 |
PE ratio (TTM) | 22.39 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.00 (0.21%) |
Ex-dividend date | 24 Jan 2024 |
1y target est | N/A |
Wipro GE Healthcare, a joint venture of India's Wipro Enterprises and a wholly owned entity of U.S.-based GE Healthcare, said it would invest 80 billion rupees ($960 million) in the country in its manufacturing and research and development facilities. Bengaluru-based medical technology company Wipro GE Healthcare said on Tuesday the investment would be done over the next five years to boost local manufacturing as it focuses on growing its footprint in the country in line with the government's "Make in India" initiative.
Wipro GE Healthcare, a joint venture of India's Wipro Enterprises and a wholly owned entity of U.S.-based GE Healthcare, said it would invest 80 billion rupees ($960 million) in the country in its manufacturing and research and development facilities. Bengaluru-based medical technology company Wipro GE Healthcare said on Tuesday the investment would be done over the next five years to boost local manufacturing as it focuses on growing its footprint in the country in line with the government's "Make in India" initiative.
Nutanix (NTNX) expands its partnership with Wipro to introduce a new business unit focused on NTNX's technologies.